Molecular Mechanisms of Drug Resistance in Glioblastoma
Glioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, is highly resistant to conventional radiation and chemotherapy, and is not amenable to effective surgical resection. The present review summarizes recent advances in our understanding of the molecular mechanisms of thera...
Main Authors: | Maya A. Dymova, Elena V. Kuligina, Vladimir A. Richter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/12/6385 |
Similar Items
-
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
by: Satya Siva Kishan Yalamarty, et al.
Published: (2023-04-01) -
Molecular Docking and Molecular Dynamics Studies Reveal Secretory Proteins as Novel Targets of Temozolomide in Glioblastoma Multiforme
by: Sumera, et al.
Published: (2022-10-01) -
Investigating acquired temozolomide resistance in adult glioblastoma
by: Wong, ZY
Published: (2020) -
Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management
by: Brandon Edelbach, et al.
Published: (2024-03-01) -
Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01)